Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

Similar articles for PubMed (Select 18317728)

1.

Beta cell mass in diabetes: a realistic therapeutic target?

Meier JJ.

Diabetologia. 2008 May;51(5):703-13. doi: 10.1007/s00125-008-0936-9. Epub 2008 Mar 4. Review.

PMID:
18317728
2.

Can thiazolidinediones delay disease progression in type 2 diabetes?

Leiter LA.

Curr Med Res Opin. 2006 Jun;22(6):1193-201. Review.

PMID:
16846552
3.

Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.

Lupi R, Del Prato S.

Diabetes Metab. 2008 Feb;34 Suppl 2:S56-64. doi: 10.1016/S1262-3636(08)73396-2. Review.

PMID:
18640587
4.

Protection of pancreatic beta-cells: is it feasible?

Bonora E.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. Review.

PMID:
18096375
5.

Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough.

Ablamunits V, Sherry NA, Kushner JA, Herold KC.

Ann N Y Acad Sci. 2007 Apr;1103:19-32. Epub 2007 Mar 21. Review.

PMID:
17376841
6.

beta-cell function and anti-diabetic pharmacotherapy.

Del Prato S, Bianchi C, Marchetti P.

Diabetes Metab Res Rev. 2007 Oct;23(7):518-27. Review.

PMID:
17883249
7.

An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.

Marchetti P, Dotta F, Lauro D, Purrello F.

Regul Pept. 2008 Feb 7;146(1-3):4-11. Epub 2007 Aug 29. Review.

PMID:
17889380
8.

Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.

Donath MY, Böni-Schnetzler M, Ellingsgaard H, Ehses JA.

Physiology (Bethesda). 2009 Dec;24:325-31. doi: 10.1152/physiol.00032.2009. Review.

9.

Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.

Yang Z, Chen M, Carter JD, Nunemaker CS, Garmey JC, Kimble SD, Nadler JL.

Biochem Biophys Res Commun. 2006 Jun 9;344(3):1017-22. Epub 2006 Apr 5.

PMID:
16643856
10.

Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC.

Diabetologia. 2005 Nov;48(11):2221-8. Epub 2005 Oct 5.

PMID:
16205882
11.

Early use of insulin for beta cell preservation.

Kumar A.

J Assoc Physicians India. 2007 Jul;55 Suppl:26-8. Review. No abstract available.

PMID:
17927008
12.

Apoptosis in the pathophysiology of diabetes mellitus.

Lee SC, Pervaiz S.

Int J Biochem Cell Biol. 2007;39(3):497-504. Epub 2006 Oct 4. Review.

PMID:
17074529
13.

Beta-cell failure in type 2 diabetes mellitus.

Lencioni C, Lupi R, Del Prato S.

Curr Diab Rep. 2008 Jun;8(3):179-84. Review.

PMID:
18625113
14.

Fate of the beta-cell in the pathophysiology of type 2 diabetes.

Campbell RK.

J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. doi: 10.1331/JAPhA.2009.09076. Review.

PMID:
19801360
15.

Investigational agents that protect pancreatic islet beta-cells from failure.

Aston-Mourney K, Proietto J, Andrikopoulos S.

Expert Opin Investig Drugs. 2005 Oct;14(10):1241-50. Review.

PMID:
16185166
16.
17.

The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.

Eizirik DL, Colli ML, Ortis F.

Nat Rev Endocrinol. 2009 Apr;5(4):219-26. doi: 10.1038/nrendo.2009.21. Review.

PMID:
19352320
18.

Preservation of beta-cell function in type 2 diabetes.

Nyalakonda K, Sharma T, Ismail-Beigi F.

Endocr Pract. 2010 Nov-Dec;16(6):1038-55. doi: 10.4158/EP10112.RA. Review.

PMID:
21030360
19.

Beta cells in type 2 diabetes - a crucial contribution to pathogenesis.

Maedler K.

Diabetes Obes Metab. 2008 May;10(5):408-20. Epub 2007 Apr 19. Review.

PMID:
17451426
20.

The replication of beta cells in normal physiology, in disease and for therapy.

Butler PC, Meier JJ, Butler AE, Bhushan A.

Nat Clin Pract Endocrinol Metab. 2007 Nov;3(11):758-68. Review.

PMID:
17955017
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk